Merck is pouring over €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. This marks the largest investment by Merck's Life Science sector in...
Merck will open a new € 20 million distribution center in São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be...
German chemicals, pharmaceuticals and life sciences group Merck has opened a digital hub in Singapore, the first outside of the US and Europe for its digital business.
Merck has expanded its Biologics Testing Center in China with 1,500 m2 of new biosafety laboratories. The company is investing a total of €29 million in its testing...
Daiichi Sankyo and Merck & Co. to co-develop and commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates worldwide except for Japan where...
Merck is the first CTDMO (contract testing, development, and manufacturing organization) to offer an integrated service covering all critical phases of mRNA development...
Germany’s Merck said this week it has signed a non-binding Memorandum of Understanding (MoU) with South Korea’s Ministry of Trade, Industry and Energy (MOTIE), and...
Anyone working in a laboratory must familiarize themselves with rules and precautions for working safely. In day-to-day laboratory work, it is often not easy to keep...
The Life Science business segment of German pharmaceuticals, chemicals and life sciences group Merck has widened its US plant for high-potent active pharmaceutical...
There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by...
The Innovation Cup is an initiative for post-graduate students and young professionals in natural sciences, computer sciences, and business administration to attend a...
15.10.2019
- Germany’s Merck KGaA said it has acquired FloDesign Sonics, Wilbraham, Massachusetts, USA-based developer of a unique acoustic cell processing platform for the industrialization of...
13.02.2015
- German chemical and pharmaceuticals producer Merck KGaA and its UK cooperation partner, flexible electronics specialist FlexEnable, a unit of Plastic Logic, have developed a...
05.07.2013
- Corporate rating agencies Moody's and Standard & Poor's (S&P) have both recently upgraded the credit ratings of German chemical and pharmaceutical producer Merck KGaA. This is the...
05.09.2011
- Merck KGaA said its laboratory specialists unit Millipore sees China as one of the strongest growth markets and expects to expand its drug-development technology and services...
10.05.2011
- Merck KGaA resumed normal operations at the Onahama production site in Japan on May 8. Among other products, the Onahama site manufactures Xirallic effect pigments, which are...
01.02.2011
- Germany's Merck KGaA may sell its non-prescription drugs business, the group's chief executive told the Financial Times, in the latest sign of change at the family-controlled drugs...
26.01.2011
- Merck KGaA received instant approval from investors as it hired Matthias Zachert, the finance chief of German specialty chemicals group Lanxess, as its CFO. Shares in Merck gained...
21.01.2011
- European regulators dealt Merck KGaA another blow by sticking with their recommendation against what once was the group's biggest pipeline hope, multiple sclerosis (MS) pill...
21.01.2011
- European regulators dealt Merck KGaA another blow by sticking with their recommendation against what once was the group's biggest pipeline hope, multiple sclerosis (MS) pill...
05.01.2011
- Merck KGaA has acquired 100% of the share capital of Beijing Skywing Technology, a leading supplier of cell-culture media products, related technical services and bioreactors for...
07.12.2010
- German drugmaker Merck KGaA will take a breather from pursuing larger takeover deals as it integrates its latest acquisition Millipore, a company executive said on Tuesday. "You...
20.10.2010
- The head of Germany's Merck KGaA, the world's largest supplier of liquid crystals for flat panel displays, warned that this year's massive upswing in key chemical markets could...
24.09.2010
- With the opening of the new Material Research Center (MRC), German pharmaceutical and chemical company Merck is underscoring the importance of chemical research at its corporate...
14.09.2010
- Like nearly all aspects of public and private business, healthcare management organizations and national governments are feeling price pressure, and many look to mitigate this by...
14.09.2010
- Smart Move - There are various reasons for companies to make acquisitions: expansion, investment, synergies, elimination of a competitor and strategy. The acquisition of Millipore...
03.08.2010
- All four divisions of the Merck Group, especially the chemicals divisions, recorded increases in Q2 2010 revenues, leading to a record €2,208 million in total revenues for the...
05.03.2010
- Global pharmaceutical and chemical company Merck KGaA headquartered in Darmstadt, Germany, will acquire Millipore Corporation, a leading Life Science company based in Billerica, U...
02.03.2010
- Germany's family-controlled Merck KGaA agreed to buy U.S. biotech tool maker Millipore for $6 billion to diversify away from its embattled drugs business. While analysts said the...
02.03.2010
- Merck KGaA's agreed $6 billion cash purchase of U.S. biotech tool maker Millipore buoyed the German drugmaker's share on Monday as it diversified away from its embattled...
01.03.2010
- Germany's Merck KGaA on Sunday said it agreed to buy U.S. biotech tool maker Millipore for around $6 billion in cash, as the company looks to build its lab equipment business...
22.01.2010
- Merck KGaA has mulled acquisitions in both the pharmaceutical and chemical industries and has sufficient funds for big targets, its chief executive told a German newspaper. "In...
22.01.2010
- Merck KGaA has announced that it has started construction work at its Darmstadt, Germany, site on a production plant for the manufacture of inorganic salts. This will increase...
The poor healing ability of tendons as well as the limitations of currently used therapies have motivated tissue engineering (TE) strategies to develop living tendon...
